Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report
The Washington DC Harris rider 2025 cannabis sales debate remains a key barrier between the District's robust local support for a regulated cannabis market and its continued reliance on an unregulated "gifting" economy. As of September 2025, Congress has once again moved to retain the so-called Harris rider in appropriations, maintaining a federal blockade against DC using local funds to launch a commercial adult-use cannabis retail system. This means adult-use retail licensing and regulatory frameworks remain on indefinite hold, despite years of preparation and advocacy from the city government.
The Harris rider is a Congressional budget restriction, first introduced in 2014 by Rep. Andy Harris, that forbids Washington DC from using local or federal funds to regulate or launch commercial marijuana sales—even though DC voters approved adult-use legalization in 2014.
While retail adult-use sales remain blocked, DC’s medical cannabis program has expanded significantly in 2024-2025. New legislation raised patient purchase limits, improved reciprocity for out-of-state patients (now covering over 40 states), and greenlit additional licensed dispensaries. As of March 2025, DC registered over 30,000 active medical patients, and licensed dispensaries sold record amounts—$3.6 million in March alone, according to ABCA.
New medical dispensaries are opening at a rapid pace, with more than 50 fully licensed as of mid-2025 and over 150 conditional licenses granted. However, these shops must strictly serve medical patients, conduct age verification, and comply with comprehensive seed-to-sale tracking, product testing, and packaging standards.
Due to the Harris rider, DC has never been able to license true adult-use (non-medical) retailers. As a workaround, hundreds of so-called gifting shops emerged, exploiting a loophole where cannabis was offered as a “gift” with the purchase of another product.
Recent legislative and regulatory developments signal the end of the city's informal tolerance for this gray area. A major enforcement grace period expired on March 31, 2025, after which the Alcoholic Beverage and Cannabis Administration (ABCA) and Metropolitan Police have rapidly escalated raids and padlock operations. By April 2025, over 50 unlicensed shops were forcibly shut, with authorities vowing strict, on-the-spot closures for future violators (Axios).
Key Enforcement Developments:
Licensed medical operators enjoy expanded market opportunities, but face robust compliance expectations:
Unlicensed gifting and “pop-up” stores now face an extremely high risk of:
Attempting to operate outside of the medical model invites severe consequences in 2025.
DC’s stalled adult-use rollout has significantly hampered the city’s social equity ambitions. While some applicants with prior cannabis convictions have found avenues through the medical system’s expansion, the promise of a comprehensive, equity-focused retail market remains deferred until Congressional action.
Local activists and lawmakers continue to pursue avenues for supporting “legacy operators,” including technical assistance and business training for those whose gifting shops are forced to close. However, until the Harris rider is repealed or modified, large-scale social equity outcomes are unlikely.
For those seeking to enter or remain in the industry:
As of September 2025, there are no strong indications that the Harris rider will be dropped from the federal budget in the FY 2025 cycle—despite significant advocacy from DC officials and residents. However, stakeholders should carefully watch the House/Senate conference process and final omnibus language for any late-breaking shifts.
Do Not Assume Recreational Retail Rollout Timelines:
Stay informed and stay compliant! For tailored guidance on Washington D.C. cannabis regulations and real-time updates, rely on CannabisRegulations.ai as your trusted compliance resource.